GAPDH |
Forward |
5′-CCACCCAGAAGACTGTGGAT-3′ |
127 |
Reverse |
5′-TTCAGCTCAGGG ATGACCTT-3′ |
TGF-β1 |
Forward |
5′-AAGGGCTACCATGCCAACTTC-3′ |
62 |
Reverse |
5′-TGCGTGTCCAGGCTCCA-3′ |
COX-2 |
Forward |
5′-CAGCACTTCACGCATCAGTT-3′ |
127 |
Reverse |
5′-CGCAGTTTACGCTGTCTAGC-3′ |
VEGF |
Forward |
5′-ATGACGAGGGCCTGGAGTGTG-3′ |
91 |
Reverse |
5′-CCTATGTGCTGGCCTTGG TGAG-3′ |
ER-1α |
Forward |
5′-CCACCAACCAGTGCACCATT-3′ |
108 |
Reverse |
5′-GGTCTTTTCGTATCCCACCTTTC-3′ |
PR |
Forward |
5′-CGCGCTCTACCCTGCACTC-3′ |
121 |
Reverse |
5′-TGAATCCGGCCTCAGGTAGTT-3′ |
AR |
Forward |
5′-CCTGGCTTCCGCAACTTACAC-3′ |
168 |
Reverse |
5′-GGACTTGTGCATGCGGTACTCA-3′ |
Aromatase (CYP19) |
Forward |
5′-CTAAATTGCCCCCTCTGAGGT-3′ |
150 |
Reverse |
5′-CCACACCAAGAGAAAAAGGCC-3′ |